Newsletter | August 29, 2026
FEATURED EDITORIAL
The U.S. Supply-Chain Uncovered: A Superior Search For Domestic Suppliers
By Louis Garguilo, Chief Editor, Outsourced Pharma
In Bioprocessing, Trusted Data Is A Process Variable
By Jason Herche, Pinnaql
Pharma Outsourcing Is Evolving. Cold Chain Monitoring Shows Why
Don't Let Your CDMO Define Quality for You
By Devanshi Doshi and Sagi Nahum, CellVira
Six Critical Decisions That Shape Oligonucleotide Scale-Up Success
By Jeffrey S. Buguliskis, Ph.D., Deputy Chief Editor, Outsourced Pharma
Lower Court Agrees With WuXi AppTec (And Many Of Us)
July Update — U.S. Generic Drug Tariffs: Implications For Pharma And Outsourcing
By Mathini Ilancheran, R&D, Beroe Inc.
By Louis Garguilo, chief editor, Outsourced Pharma
CSV Assumes The AI System Sits Still — It Doesn't.
By Sachin Bhandari, TrustBridge Compliance
For Bispecific Ab Programs, Measure Twice And Outsource Once
By Jeffrey S. Buguliskis, Ph.D., deputy chief editor, Outsourced Pharma
Unlocking MES Value: Why Technology Isn't The Real Challenge
By Ciera Clayton, BioPhorum
INDUSTRY INSIGHTS
Using Digital Tools In Process Development
By Dr. Alexander Krauland and Hermann Schuchnigg, Boehringer Ingelheim Biopharmaceuticals GmbH
Accelerating Biologics With Seamless Technology Transfer
By Sangkyu Hwang and Brian Heo, Samsung Biologics
CDMO Partnerships: Why Speed And Flexibility Matter Now More Than Ever
By Miguel Ángel Ortega Sánchez, ROIS
Enriching Sterile Fill/Finish Services With A Patient-Centric Approach
Grand River Aseptic Manufacturing
Designing And Selecting Antibody-Oligonucleotide Conjugates
By Campbell Bunce, Nicolas Camper, Arron Hearn, et al., Abzena
Mitigating Fill Risk In Drug Product Manufacturing
WuXi Biologics
Strategic Hiring For Scalable Success
August Bioservices
Increasing Batch Size And Reducing Cycle Times For A Biologic
Jubilant HollisterStier
Building Quality By Design For Multi-Specific Therapeutic Proteins
Lonza
The Benefits Of End-To-End Formulation And Fill/Finish Of Biologics
By Tyler Jones, Ph.D. and Geno Worke, Curia
Three Keys To E&L Success: Study Design, Partner Selection, And Timing
By Vicki Ward, Ph.D., Pace® Life Sciences
Collaborative Variability Reduction In Cell Culture Media
Nu-Tek Biosciences
Speeding Up Safety: An Evaluation Of Mycoplasma Technology
Minaris
The Importance Of Quality In Raw Material Selection
Thermo Fisher Scientific
Achieving Cell Therapy Success: Reducing Costs To Improve Patient Access
Resilience
How Data-Driven Development Is Transforming Phosphoramidites
Flamma
Accelerate Efficiency By Decoupling Collection From Manufacturing
Cryoport Systems
The Critical Bottleneck In Personalized Cancer Vaccines
4basebio
CDMOs Evolve IT Validation Strategies To Stay Ahead
Andelyn Biosciences
A Smarter Strategy For Higher AAV Yields
Automated T-Cell Manufacturing At Scale
By Chesney Michels, ElevateBio
What Sponsors Get Wrong When Selecting A CRO
Dash Bio
Making A Meaningful Impact In AAV
Viralgen
xRNA Production: The Economic Case For Continuous Manufacturing
By Aaron B. Cowley, Ph.D., Recipharm Advanced Bio
Time: A Crucial Factor In Therapeutics Development
Aldevron
What Everyone Needs To Know About Polymorphs
Curia
Complex Molecules, Complex Problems
By Charles Johnson, Lonza
Formulation & Delivery Of Spray Dried Biologics For Nasal Dosage Forms
Upperton Pharma Solutions
Addressing Regulatory Challenges For Ophthalmic Combination Products
By Jeffrey Tremain and Ania VanDyke, AbbVie
Safely Scaling High Potency API Manufacturing
Recipharm
Re-Thinking ASD Development: When Your Molecule Breaks The Rules
AustinPx
Assessing Developability And Designing Advanceable Formulations
By Nazar Elkarim, Ph.D., Mikart
Navigating Downstream Processing (DSP)
Operational Readiness Frameworks For Pharma And Biotech
By Paige Kane, Ph.D., CAI
Increasing Success Rates In Your Drug Discovery Research
Leveraging Bio-Functional Assays For Charged Variants Characterization
Catalent
Shaping The Next Era Of Biologics Manufacturing In North Carolina
By Laurie Braxton, FUJIFILM Biotechnologies
Soluble Versus Insoluble Expression In Microbial Fermentation
By Nikolay Krumov and Jonas Mueller, Lonza
Integrated Analytical Development For Biosimilar Comparability Studies
Rezon Bio
De-Risking A Novel Valve Component For Use With Standard Syringe Systems
By Marc Flippe and Sophie Lelias, BD Medical - Pharmaceutical Systems
How Confident Are You In Your Autoinjector?
Solvias
Periodic Counter Current Chromatography: A Step Toward Continuous DSP
By Antonio Ginés García Saura and Ingrid Long, AGC Biologics
Doubling Up For Speed In Biomanufacturing
Cytiva
Driving Rapid Development Of Complex Biologics
KBI Biopharma
Accelerating Bulk Harvest Release Testing With A PCR-Based Solution
MilliporeSigma
Softgel Formulation Strategies For Challenging Oral Compounds
Douglas CDMO
Designing Shelf-Stable, Dry Powder Vaccines To Improve Global Access
By Sana Hosseini, Kim Shepard, and John Chen, Lonza
Innovative Softgel Technologies To Deliver Poorly Soluble Molecules
Optimizing Bioavailability With Predictive Science
Fast-Tracking FIH To PoC: Strategies For Accelerated Drug Development
Quotient Sciences
Choosing A CDMO: 3 Considerations For New Drug Developers
Liquid-Filled Hard Capsules: Applications In Drug Development
Altasciences
